A Study of DeTIL-0255 in Adults With Advanced Malignancies

NCT05107739 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Platinum-resistant Ovarian Cancer
Endometrial Cancer
Cervical Cancer

Interventions

BIOLOGICAL: Drug Product De-TIL-0255

Sponsor

Nurix Therapeutics, Inc.